SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-072874
Filing Date
2020-03-13
Accepted
2020-03-13 16:07:05
Documents
4
Effectiveness Date
2020-03-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d859211ds8.htm S-8 47855
2 EX-5.1 d859211dex51.htm EX-5.1 6816
3 EX-23.2 d859211dex232.htm EX-23.2 1479
4 GRAPHIC g859211cm007.jpg GRAPHIC 3900
  Complete submission text file 0001193125-20-072874.txt   62718
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237156 | Film No.: 20712691
SIC: 2836 Biological Products, (No Diagnostic Substances)